Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Al B Benson

Showing results (231-240 of 350) with videos related to

Pageof 35
Sort By:
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 18, 2021
Correction to: Health-related quality of life in advanced gastric/gastroesophageal junction cancer with second-line pembrolizumab in KEYNOTE-061Eric Van Cutsem, Mayur Amonkar, Charles S Fuchs, et al.
Journal of Oncology Practice|September 1, 2016
Care for a Patient With Cancer As a Project: Management of Complex Task Interdependence in Cancer Care DeliveryJulia R Trosman, Ruth C Carlos, Melissa A Simon, et al.
International Journal of Radiation Oncology, Biology, Physics|December 6, 2011
Radioembolization for neuroendocrine liver metastases: safety, imaging, and long-term outcomesKhairuddin Memon, Robert J Lewandowski, Mary F Mulcahy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 8, 2011
Predictive and prognostic roles of BRAF mutation in stage III colon cancer: results from intergroup trial CALGB 89803Shuji Ogino, Kaori Shima, Jeffrey A Meyerhardt, et al.
JCO Precision Oncology|August 11, 2022
Immunoscore Is Prognostic in Low-Risk and High-Risk Stage III Colon Carcinomas Treated With Adjuvant Infusional Fluorouracil, Leucovorin, and Oxaliplatin in a Phase III TrialFrank A Sinicrope, Qian Shi, Aurelie Catteau, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|August 7, 2021
Health-related quality of life in advanced gastric/gastroesophageal junction cancer with second-line pembrolizumab in KEYNOTE-061Eric Van Cutsem, Mayur Amonkar, Charles S Fuchs, et al.
Gastroenterology|August 31, 2016
Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular CarcinomaRiad Salem, Andrew C Gordon, Samdeep Mouli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2017
Cetuximab Plus Chemoradiotherapy in Immunocompetent Patients With Anal Carcinoma: A Phase II Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group Trial (E3205)Madhur K Garg, Fengmin Zhao, Joseph A Sparano, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 6, 2020
Quality Measurement in Cancer Care: A Review and Endorsement of High-Impact Measures and ConceptsThomas A D'Amico, Lindsey A M Bandini, Alan Balch, et al.
JAMA|March 18, 2010
Imaging response in the primary index lesion and clinical outcomes following transarterial locoregional therapy for hepatocellular carcinomaAhsun Riaz, Frank H Miller, Laura M Kulik, et al.
Pageof 35

Showing results (231-240 of 350) with videos related to

Sort By:
Pageof 35
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 18, 2021
Correction to: Health-related quality of life in advanced gastric/gastroesophageal junction cancer with second-line pembrolizumab in KEYNOTE-061Eric Van Cutsem, Mayur Amonkar, Charles S Fuchs, et al.
Journal of Oncology Practice|September 1, 2016
Care for a Patient With Cancer As a Project: Management of Complex Task Interdependence in Cancer Care DeliveryJulia R Trosman, Ruth C Carlos, Melissa A Simon, et al.
International Journal of Radiation Oncology, Biology, Physics|December 6, 2011
Radioembolization for neuroendocrine liver metastases: safety, imaging, and long-term outcomesKhairuddin Memon, Robert J Lewandowski, Mary F Mulcahy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 8, 2011
Predictive and prognostic roles of BRAF mutation in stage III colon cancer: results from intergroup trial CALGB 89803Shuji Ogino, Kaori Shima, Jeffrey A Meyerhardt, et al.
JCO Precision Oncology|August 11, 2022
Immunoscore Is Prognostic in Low-Risk and High-Risk Stage III Colon Carcinomas Treated With Adjuvant Infusional Fluorouracil, Leucovorin, and Oxaliplatin in a Phase III TrialFrank A Sinicrope, Qian Shi, Aurelie Catteau, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|August 7, 2021
Health-related quality of life in advanced gastric/gastroesophageal junction cancer with second-line pembrolizumab in KEYNOTE-061Eric Van Cutsem, Mayur Amonkar, Charles S Fuchs, et al.
Gastroenterology|August 31, 2016
Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular CarcinomaRiad Salem, Andrew C Gordon, Samdeep Mouli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2017
Cetuximab Plus Chemoradiotherapy in Immunocompetent Patients With Anal Carcinoma: A Phase II Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group Trial (E3205)Madhur K Garg, Fengmin Zhao, Joseph A Sparano, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 6, 2020
Quality Measurement in Cancer Care: A Review and Endorsement of High-Impact Measures and ConceptsThomas A D'Amico, Lindsey A M Bandini, Alan Balch, et al.
JAMA|March 18, 2010
Imaging response in the primary index lesion and clinical outcomes following transarterial locoregional therapy for hepatocellular carcinomaAhsun Riaz, Frank H Miller, Laura M Kulik, et al.
Pageof 35